RAS Inhibitor Daraxonrasib Shows 35% Response Rate in Pancreatic Cancer
Pancreatic cancer's notorious resistance to treatment may finally face a meaningful challenge. With five-year survival rates below 12%, this malignancy…
Found 1715 results for "cancer"
Pancreatic cancer's notorious resistance to treatment may finally face a meaningful challenge. With five-year survival rates below 12%, this malignancy…
Triple-negative breast cancer represents one of the most aggressive malignancies, with limited treatment options and high metastatic potential that devastates…
Pancreatic ductal adenocarcinoma remains one of medicine's most formidable challenges, with five-year survival rates below 10% and limited therapeutic options…
Pancreatic cancer remains one of oncology's most formidable challenges, with five-year survival rates below 12% and limited treatment options once first-line…
The intersection of genetic risk factors may fundamentally alter how clinicians assess breast cancer susceptibility in men, particularly those developing the…
Men facing aggressive prostate cancer surgery now have compelling evidence for a treatment approach that could dramatically reduce their chances of disease…
Precision medicine has taken another significant leap forward with compelling evidence that targeting specific genetic drivers before cancer spreads could…
Chronic stress wreaks havoc on multiple body systems simultaneously, but medicine has lacked precise tools to measure this cumulative damage before diseases…
Glioblastoma represents medicine's most formidable oncological challenge, with median survival rarely exceeding 15 months despite aggressive treatment. The…
A comprehensive survey of 1,000 adults in Nouakchott, Mauritania's capital, reveals a concerning cancer risk landscape: 66.6% are overweight or obese, 58%…
Advanced prostate cancer treatment is shifting toward molecularly-guided therapy combinations that could dramatically improve survival outcomes for men with…
The persistence of aggressive breast cancer patterns in Black women demands urgent attention from both clinicians and patients navigating early detection…
Advanced cancer patients facing treatment failure may soon have a new therapeutic option through precision immunotherapy targeting previously untouchable…
Cost barriers to cancer immunotherapy may have met their match through a dosing strategy that dramatically reduces expense while preserving clinical benefit…
Childhood neuroblastoma diagnosis could become more precise and accessible as artificial intelligence proves capable of identifying cancer spread through…
Blood cancer patients face a critical window where molecular traces of disease predict impending relapse, yet standard surveillance offers little…
The nuclear protein YTHDC1 directly binds to m6A-modified TERT mRNA transcripts, stabilizing telomerase expression and preventing telomere shortening in…
The pursuit of more precise lung disease diagnosis just gained significant momentum with evidence that freezing-based biopsy tools may fundamentally improve…
Women with hormone-positive metastatic breast cancer face critical treatment decisions after initial chemotherapy stabilizes their disease. The choice of…
Pancreatic ductal adenocarcinoma stands as medicine's most stubborn adversary, with five-year survival rates below 12 percent. The disease's notorious…